Abstract
PURPOSE: This in vitro study reports estimates of lung delivery of the two asthma medications Xopenex HFA and Flovent HFA delivered via Vortex and AeroChamber holding chambers. Such information is useful in guiding clincians’ choice of a holding chamber for a specific MDI.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
